Alyeska Investment Group »

Aytu Biopharma shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $232k 82k 2.84
2023-03-31 $168k 75k 2.24

More positions owned by Alyeska Investment Group

Meta Platforms Cl A (META)
Aercap Holdings Nv SHS (AER)
Take-Two Interactive Software (TTWO)
Epam Systems (EPAM)
Dollar General (DG)
Paycom Software (PAYC)
Twilio Cl A (TWLO)
Burlington Stores (BURL)
Lauder Estee Cos Cl A (EL)
Adobe Systems Incorporated (ADBE)
Oracle Corporation (ORCL)
Autodesk (ADSK)
Xylem (XYL)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Amazon (AMZN)

View all positions for Alyeska Investment Group

Top funds holding Aytu Biopharma

Nantahala Capital Management
Alyeska Investment Group
Vanguard Group
Goldman Sachs Group
Jpmorgan Chase & Co
Royal Bank of Canada
Advisor Group Holdings
UBS Group
Wells Fargo & Company
West Financial Advisors
CarsonAllaria Wealth Management
Citigroup
TSFG

View all funds holding Aytu Biopharma